| Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity. | Loss of ATRX and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity.
Yasunaga Y, Tanaka M, Arita J, Hasegawa K, Ushiku T. | 08/3/2024 |
| The translocation activity of Rad54 reduces crossover outcomes during homologous recombination. | The translocation activity of Rad54 reduces crossover outcomes during homologous recombination.
Sridalla K, Woodhouse MV, Hu J, Scheer J, Ferlez B, Crickard JB., Free PMC Article | 08/1/2024 |
| ATRX guards against aberrant differentiation in mesenchymal progenitor cells. | ATRX guards against aberrant differentiation in mesenchymal progenitor cells.
Fang Y, Barrows D, Dabas Y, Carroll TS, Singer S, Tap WD, Nacev BA., Free PMC Article | 06/12/2024 |
| Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice. | Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice.
Fuentes ME, Lu X, Flores NM, Hausmann S, Mazur PK., Free PMC Article | 04/17/2024 |
| Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma. | Multiparametric MRI and T2/FLAIR mismatch complements the World Health Organization 2021 classification for the diagnosis of IDH-mutant 1p/19q non-co-deleted/ATRX-mutant astrocytoma.
Sawlani V, Jen JP, Patel M, Jain M, Haq H, Ughratdar I, Wykes V, Nagaraju S, Watts C, Pohl U. | 02/16/2024 |
| DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks. | DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.
Pinto LM, Pailas A, Bondarchenko M, Sharma AB, Neumann K, Rizzo AJ, Jeanty C, Nicot N, Racca C, Graham MK, Naughton C, Liu Y, Chen CL, Meakin PJ, Gilbert N, Britton S, Meeker AK, Heaphy CM, Larminat F, Van Dyck E., Free PMC Article | 02/14/2024 |
| Integrated omics analyses clarifies ATRX copy number variant of uncertain significance. | Integrated omics analyses clarifies ATRX copy number variant of uncertain significance.
Marshall AE, Liang Y, Couse M, McConkey H, Care4Rare Canada Consortium, Sadikovic B, Boycott KM, Dyment DA, Kernohan KD. | 02/6/2024 |
| ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network. | ATRX is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network.
Qian H, Ji R, Shen C, Wei Y, Sheng C, Ni Q, Pan J, Chi Y, You H, Miao Y, Shi M, Huang X, Shen A., Free PMC Article | 01/27/2024 |
| MYCN amplification, TERT rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective. | MYCN amplification, TERT rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective.
Kerkar AN, Chinnam D, Verma A, Peters NJ, Kakkar N, Trehan A, Singh M, Gupta K. | 11/1/2023 |
| Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts. | Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts.
Udroiu I, Marinaccio J, Sgura A., Free PMC Article | 09/6/2023 |
| Two opposing gene expression patterns within ATRX aberrant neuroblastoma. | Two opposing gene expression patterns within ATRX aberrant neuroblastoma.
van Gerven MR, Schild L, van Arkel J, Koopmans B, Broeils LA, Meijs LAM, van Oosterhout R, van Noesel MM, Koster J, van Hooff SR, Molenaar JJ, van den Boogaard ML., Free PMC Article | 08/7/2023 |
| A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defects. | A new mouse model of ATR-X syndrome carrying a common patient mutation exhibits neurological and morphological defects.
Tillotson R, Yan K, Ruston J, DeYoung T, Córdova A, Turcotte-Cardin V, Yee Y, Taylor C, Visuvanathan S, Babbs C, Ivakine EA, Sled JG, Nieman BJ, Picketts DJ, Justice MJ., Free PMC Article | 07/31/2023 |
| Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.
Stundon JL, Ijaz H, Gaonkar KS, Kaufman RS, Jin R, Karras A, Vaksman Z, Kim J, Corbett RJ, Lueder MR, Miller DP, Guo Y, Santi M, Li M, Lopez G, Storm PB, Resnick AC, Waanders AJ, MacFarland SP, Stewart DR, Diskin SJ, Rokita JL, Cole KA., Free PMC Article | 07/10/2023 |
| ATRX, a guardian of chromatin. | ATRX, a guardian of chromatin.
Aguilera P, López-Contreras AJ. | 05/18/2023 |
| Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions. | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Bogumil H, Sill M, Schrimpf D, Ismer B, Blume C, Rahmanzade R, Hinz F, Cherkezov A, Banan R, Friedel D, Reuss DE, Selt F, Ecker J, Milde T, Pajtler KW, Schittenhelm J, Hench J, Frank S, Boldt HB, Kristensen BW, Scheie D, Melchior LC, Olesen V, Sehested A, Boué DR, Abdullaev Z, Satgunaseelan L, Kurth I, Seidlitz A, White CL, Ng HK, Shi ZF, Haberler C, Deckert M, Timmer M, Goldbrunner R, Tauziède-Espariat A, Varlet P, Brandner S, Alexandrescu S, Snuderl M, Aldape K, Korshunov A, Witt O, Herold-Mende C, Unterberg A, Wick W, Pfister SM, von Deimling A, Jones DTW, Sahm F, Sievers P., Free PMC Article | 04/26/2023 |
| DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis. | DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis.
Gisder DM, Overheu O, Keller J, Nöpel-Dünnebacke S, Uhl W, Reinacher-Schick A, Tannapfel A, Tischoff I. | 04/17/2023 |
| TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT. | TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT.
de Nonneville A, Salas S, Bertucci F, Sobinoff AP, Adélaïde J, Guille A, Finetti P, Noble JR, Churikov D, Chaffanet M, Lavit E, Pickett HA, Bouvier C, Birnbaum D, Reddel RR, Géli V., Free PMC Article | 10/15/2022 |
| Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-kappaB signaling and integrin binding. | Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding.
Bartholf DeWitt S, Hoskinson Plumlee S, Brighton HE, Sivaraj D, Martz EJ, Zand M, Kumar V, Sheth MU, Floyd W, Spruance JV, Hawkey N, Varghese S, Ruan J, Kirsch DG, Somarelli JA, Alman B, Eward WC., Free PMC Article | 09/17/2022 |
| ATRX protein is a potential prognostic marker in clear cell renal cell carcinoma. | ATRX protein is a potential prognostic marker in clear cell renal cell carcinoma.
Baek J, Jang NR, Shim YR, Gu MJ. | 08/6/2022 |
| Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors. | Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors.
Yaltirik CK, Yilmaz SG, Ozdogan S, Bilgin EY, Barut Z, Ture U, Isbir T., Free PMC Article | 07/2/2022 |
| Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics. | Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.
van Gerven MR, Bozsaky E, Matser YAH, Vosseberg J, Taschner-Mandl S, Koster J, Tytgat GAM, Molenaar JJ, van den Boogaard M., Free PMC Article | 06/25/2022 |
| ATRX-dependent SVCT2 mediates macrophage infiltration in the glioblastoma xenograft model. | ATRX-dependent SVCT2 mediates macrophage infiltration in the glioblastoma xenograft model.
Shang J, Wang Y, Li Z, Jiang L, Bai Q, Zhang X, Xiao G, Zhang J. | 05/7/2022 |
| ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma. | ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma.
Babikir H, Wang L, Shamardani K, Catalan F, Sudhir S, Aghi MK, Raleigh DR, Phillips JJ, Diaz AA., Free PMC Article | 03/19/2022 |
| Circular RNA mitochondrial translation optimization 1 homologue (CircMTO1) induced by zinc finger protein 460 (ZNF460) promotes oral squamous cell carcinoma progression through the microRNA miR-320a / alpha thalassemia/mental retardation, X-linked (ATRX) axis. | Circular RNA mitochondrial translation optimization 1 homologue (CircMTO1) induced by zinc finger protein 460 (ZNF460) promotes oral squamous cell carcinoma progression through the microRNA miR-320a / alpha thalassemia/mental retardation, X-linked (ATRX) axis.
Zou C, Li X, Lv X, Wu S, Song J, Tang Z, Luo H, Wei H, Ai Y., Free PMC Article | 02/19/2022 |
| The limits of clinical findings in similar phenotypes, from Carpenter to ATRX syndrome using a whole exome sequencing approach: a case review. | The limits of clinical findings in similar phenotypes, from Carpenter to ATRX syndrome using a whole exome sequencing approach: a case review.
Sáenz SS, Arias B, Hosomichi K, Romero VI., Free PMC Article | 02/5/2022 |